QuikReader
QuikReader
Latest
Top stories
Business
Tech
World
Politics
Sports
Lifestyle
Health
Science
Entertainment
More
Sources
Sign in
Business
Sources
CNBC
US Top News and Analysis
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart disease.
Read more at
CNBC
Save Story
Topics in this Story
Years
Live
Four
People
Novo Nordisk's Diabetes
Related Stories
200 years after the creation of braille, blind people in Mali say it has allowed them to fit in
ABC News
· Mar. 20
Myanmar Earthquake Aid Complicated by Its Isolation
The New York Times
· 3d
King Charles hospitalized briefly due to side effects of cancer treatment
CBS News
· 3d
GATORS PODCAST: UF goes to Final 4 after heart-stopper by the Bay (Ep. 274)
Yahoo Sports
· 6h
Knicks signing P.J. Tucker to two-year contract
Yahoo Sports
· 6h
Five people dead and four injured after explosion at Spanish coalmine
The Guardian
· 15h
Marine Le Pen banned from running for French presidency in 2027 and given four-year sentence in embezzlement trial – live
The Guardian
· 16h
Sporting KC, Vermes part ways after 16 years
ESPN
· 24m
LIVE: ABC News Live
ABC News
· 3d
More from CNBC
The 'Dirty 15' percent: Some countries will take a harder hit from Trump's tariffs
CNBC
· 4h
OpenAI closes $40 billion funding round, largest private tech deal on record
CNBC
· 1h
Tesla plunges 36% in first quarter, worst performance for any period since 2022
CNBC
· 8h
Trump tariffs jolt Asian automakers — Toyota likely set for most pain
CNBC
· 20m
Anthropic announces updates on security safeguards for its AI models
CNBC
· 2h
More in Business
China kicks off military drills near Taiwan, warns island's 'independence' means war
CNBC
· 18m
Trump tariffs jolt Asian automakers — Toyota likely set for most pain
CNBC
· 20m
International visitors pour into Japan — to the delight and dismay of its ski towns
CNBC
· 30m
Australia central bank highlights global risks as it keeps rates steady at 4.1%
CNBC
· 30m
Barclays’ private credit partner struggles to raise new funds
Financial Times
· 1h